Area of research
Cancer Research · Hepatology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Hepatitis C virus research, Protein Kinase Regulation and GTPase Signaling, and MicroRNA in disease regulation.
Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
TGF-β2 silencing to target biliary-derived liver diseases
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver disease
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study
TGF-β2 in Chronic Liver Disease (CLD) and Hepatocellular Carcinoma (HCC)
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection